Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 542

1.

Blepharoplasty Basics for the Dermatologist.

Scawn R, Gore S, Joshi N.

J Cutan Aesthet Surg. 2016 Apr-Jun;9(2):80-4. doi: 10.4103/0974-2077.184050.

2.

Social perception of morbidity in facial nerve paralysis.

Li MK, Niles N, Gore S, Ebrahimi A, McGuinness J, Clark JR.

Head Neck. 2016 Aug;38(8):1158-63. doi: 10.1002/hed.24299. Epub 2016 May 26.

PMID:
27225347
3.

Chronic myelomoncytic leukemia: Are we finally solving the identity crisis?

Nazha A, Prebet T, Gore S, Zeidan AM.

Blood Rev. 2016 Apr 25. pii: S0268-960X(16)30014-5. doi: 10.1016/j.blre.2016.04.006. [Epub ahead of print] Review.

PMID:
27162201
4.

Stressful life events, hopelessness, and suicidal intent in patients admitted with attempted suicide in a tertiary care general hospital.

Jaiswal SV, Faye AD, Gore SP, Shah HR, Kamath RM.

J Postgrad Med. 2016 Apr-Jun;62(2):102-4. doi: 10.4103/0022-3859.180556.

5.

Corrigendum to "Quantification of 5-azacytidine in plasma by electrospray tandem mass spectrometry coupled with high-performance liquid chromatography" [J. Chromatogr. B 813(1) (2004) 81-88].

Zhao M, Rudek MA, He P, Hartke C, Gore S, Carducci MA, Baker SD.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 May 1;1020:167. doi: 10.1016/j.jchromb.2016.03.018. Epub 2016 Mar 25. No abstract available.

PMID:
27063482
6.

DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia.

Meyer SE, Qin T, Muench DE, Masuda K, Venkatasubramanian M, Orr E, Suarez L, Gore SD, Delwel R, Paietta E, Tallman MS, Fernandez H, Melnick A, Le Beau MM, Kogan S, Salomonis N, Figueroa ME, Grimes HL.

Cancer Discov. 2016 May;6(5):501-15. doi: 10.1158/2159-8290.CD-16-0008. Epub 2016 Mar 25.

PMID:
27016502
7.

Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes.

Zeidan AM, Wang R, Davidoff AJ, Ma S, Zhao Y, Gore SD, Gross CP, Ma X.

Cancer. 2016 May 15;122(10):1598-607. doi: 10.1002/cncr.29945. Epub 2016 Mar 11.

PMID:
26970288
8.

Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.

Fletcher SA, Cronin AM, Zeidan AM, Odejide OO, Gore SD, Davidoff AJ, Steensma DP, Abel GA.

Cancer. 2016 Apr 15;122(8):1209-15. doi: 10.1002/cncr.29913. Epub 2016 Feb 23.

PMID:
26914833
9.

Long-term impacts of nitrogen deposition on coastal plant communities.

Pakeman RJ, Alexander J, Brooker R, Cummins R, Fielding D, Gore S, Hewison R, Mitchell R, Moore E, Orford K, Pemberton C, Trinder C, Lewis R.

Environ Pollut. 2016 May;212:337-47. doi: 10.1016/j.envpol.2016.01.084. Epub 2016 Feb 6.

PMID:
26854704
10.

Lost in translation? Ten years of development of histone deacetylase inhibitors in acute myeloid leukemia and myelodysplastic syndromes.

Stahl M, Gore SD, Vey N, Prebet T.

Expert Opin Investig Drugs. 2016;25(3):307-17. doi: 10.1517/13543784.2016.1146251.

PMID:
26807602
11.

The Number of Trials Required to Obtain a Representative Movement Pattern During a Hurdle Hop Exercise.

Gore SJ, Marshall BM, Franklyn-Miller AD, Falvey EC, Moran KA.

J Appl Biomech. 2016 Jun;32(3):295-300. doi: 10.1123/jab.2015-0121. Epub 2015 Dec 14.

PMID:
26667614
12.

Pediatric Nurse Performance on a Medication Dosage Calculation Assessment Tool.

Ridling D, Christensen P, Harder LR, Gove N, Gore S.

J Pediatr Nurs. 2016 Mar-Apr;31(2):e133-40. doi: 10.1016/j.pedn.2015.10.016. Epub 2015 Nov 28.

PMID:
26626582
13.

Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

Heap GA, So K, Weedon M, Edney N, Bewshea C, Singh A, Annese V, Beckly J, Buurman D, Chaudhary R, Cole AT, Cooper SC, Creed T, Cummings F, de Boer NK, D'Inca R, D'Souza R, Daneshmend TK, Delaney M, Dhar A, Direkze N, Dunckley P, Gaya DR, Gearry R, Gore S, Halfvarson J, Hart A, Hawkey CJ, Hoentjen F, Iqbal T, Irving P, Lal S, Lawrence I, Lees CW, Lockett M, Mann S, Mansfield J, Mowat C, Mulgrew CJ, Muller F, Murray C, Oram R, Orchard T, Parkes M, Phillips R, Pollok R, Radford-Smith G, Sebastian S, Sen S, Shirazi T, Silverberg M, Solomon L, Sturniolo GC, Thomas M, Tremelling M, Tsianos EV, Watts D, Weaver S, Weersma RK, Wesley E, Holden A, Ahmad T.

J Crohns Colitis. 2016 Feb;10(2):149-58. doi: 10.1093/ecco-jcc/jjv219. Epub 2015 Nov 29.

PMID:
26619893
14.

Brain Herniation in Neurofibromatosis with Dysplasia of Occipital Bone and Posterior Skull Base.

Rangarajan V, Mahore A, Patil M, Sathe P, Kaswa A, Gore S, Dharurkar P, Kawale J.

Case Rep Neurol Med. 2015;2015:816079. doi: 10.1155/2015/816079. Epub 2015 Oct 27.

15.

Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study.

Prebet T, Sun Z, Ketterling RP, Zeidan A, Greenberg P, Herman J, Juckett M, Smith MR, Malick L, Paietta E, Czader M, Figueroa M, Gabrilove J, Erba HP, Tallman MS, Litzow M, Gore SD; Eastern Cooperative Oncology Group and North American Leukemia intergroup.

Br J Haematol. 2016 Feb;172(3):384-91. doi: 10.1111/bjh.13832. Epub 2015 Nov 18.

16.

PDBe: improved accessibility of macromolecular structure data from PDB and EMDB.

Velankar S, van Ginkel G, Alhroub Y, Battle GM, Berrisford JM, Conroy MJ, Dana JM, Gore SP, Gutmanas A, Haslam P, Hendrickx PM, Lagerstedt I, Mir S, Fernandez Montecelo MA, Mukhopadhyay A, Oldfield TJ, Patwardhan A, Sanz-GarcĂ­a E, Sen S, Slowley RA, Wainwright ME, Deshpande MS, Iudin A, Sahni G, Salavert Torres J, Hirshberg M, Mak L, Nadzirin N, Armstrong DR, Clark AR, Smart OS, Korir PK, Kleywegt GJ.

Nucleic Acids Res. 2016 Jan 4;44(D1):D385-95. doi: 10.1093/nar/gkv1047. Epub 2015 Oct 17.

17.

Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides.

Zeidan AM, Sekeres MA, Garcia-Manero G, Steensma DP, Zell K, Barnard J, Ali NA, Zimmerman C, Roboz G, DeZern A, Nazha A, Jabbour E, Kantarjian H, Gore SD, Maciejewski JP, List A, Komrokji R; MDS Clinical Research Consortium.

Leukemia. 2016 Mar;30(3):649-57. doi: 10.1038/leu.2015.283. Epub 2015 Oct 14.

18.

Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes.

Garcia-Manero G, Gore SD, Kambhampati S, Scott B, Tefferi A, Cogle CR, Edenfield WJ, Hetzer J, Kumar K, Laille E, Shi T, MacBeth KJ, Skikne B.

Leukemia. 2016 Apr;30(4):889-96. doi: 10.1038/leu.2015.265. Epub 2015 Oct 7.

19.

Factors for early death in rabies- the bitter truth.

Senthilkumaran S, Jena NN, Gore SB, Manikam R, Thirumalaikolundusubramanian P.

Indian J Crit Care Med. 2015 Sep;19(9):566-7. doi: 10.4103/0972-5229.164823. No abstract available.

20.

Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey.

Lee EJ, Smith BD, Merrey JW, Lee AI, Podoltsev NA, Barbarotta L, Litzow MR, Prebet T, Luger SM, Gore S, Streiff MB, Zeidan AM.

Clin Lymphoma Myeloma Leuk. 2015 Dec;15(12):766-770. doi: 10.1016/j.clml.2015.07.637. Epub 2015 Aug 6.

Items per page

Supplemental Content

Write to the Help Desk